Shin and co-workers described an upregulation of glycolytic enzymes including Transketolase in 5-FU resistant colon cancer cell lines [34], an argument for the potential involvement of TKTL1 in progression and therapy resistance. The gene discussed is TKT; the disease is colonic neoplasm.